Citigroup Inc
- SEC CIK
- 0000831001
- Latest filing
- Aug 3, 2026
CADL holding history
Candel Therapeutics, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CADL overviewAll 13F holders of CADLFull Q2 2026 holdings
- Shares (Q2 2026)
- 85,510
- Value
- $880.8K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 85,510 | $880.8K | <0.1% | +64,128+299.9% | Added | Holders |
| Q1 2026 | 21,382 | $104.8K | <0.1% | +18,708+699.6% | Added | Holders |
| Q4 2025 | 2,674 | $15.1K | <0.1% | +963+56.3% | Added | Holders |
| Q3 2025 | 1,711 | $8.73K | <0.1% | −12,224−87.7% | Reduced | Holders |
| Q2 2025 | 13,935 | $70.5K | <0.1% | −6,303−31.1% | Reduced | Holders |
| Q1 2025 | 20,238 | $114.3K | <0.1% | +1,635+8.8% | Added | Holders |
| Q4 2024 | 18,603 | $161.5K | <0.1% | +4,113+28.4% | Added | Holders |
| Q3 2024 | 14,490 | $100.4K | <0.1% | +9,892+215.1% | Added | Holders |
| Q2 2024 | 4,598 | $28.5K | <0.1% | +4,598 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −118,612−100.0% | Sold out | Holders |
| Q2 2023 | 118,612 | $149.5K | <0.1% | +118,612 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −352−100.0% | Sold out | Holders |
| Q4 2022 | 352 | $630 | <0.1% | +17+5.1% | Added | Holders |
| Q3 2022 | 335 | $1.00K | <0.1% | −95−22.1% | Reduced | Holders |
| Q2 2022 | 430 | $1.00K | <0.1% | −180−29.5% | Reduced | Holders |
| Q1 2022 | 610 | $3.00K | <0.1% | −256−29.6% | Reduced | Holders |
| Q4 2021 | 866 | $7.00K | <0.1% | +866 | New | Holders |